JYNT

The Joint Corp. [JYNT] Stock Forecast

Q: What is The Joint Corp. stock symbol ?

The Joint Corp. is a US stock, located in Scottsdale of Az and trading under the symbol JYNT

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

JYNT Stock Summary

Earnings have grown 25.52% per last year.

Earnings are expected to rise 24.17% next year

EPS has been decreasing for the past 3 years (Yearly statements)

JYNT has less than 1 year of cash runway

Top 10 Correlated ETFs

JYNT

Top 10 Correlated Stocks

JYNT

In the News

02:17 29 Sep 2023 JYNT

The Joint (JYNT) Forays Into West Virginia Chiropractic Market

The Joint's (JYNT) new facility is positioned near the West Virginia University campus, at a high-traffic shopping center.

02:16 29 Sep 2023 JYNT

The Joint (JYNT) Q2 Earnings Miss Estimates, 2023 View Down

The Joint (JYNT) expects to open 100-120 franchised clinics in 2023 compared with 121 opened last year.

06:47 29 Sep 2023 JYNT

The Joint Corp. (JYNT) Reports Q2 Loss, Misses Revenue Estimates

The Joint Corp. (JYNT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.02 per share a year ago.

07:05 29 Sep 2023 JYNT

The Joint Corp. to Participate in Upcoming Conferences

SCOTTSDALE, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that management plans to participate in and conduct one-on-one meetings at these upcoming conferences.

11:40 29 Sep 2023 JYNT

The Joint Corp. (JYNT) Q2 2023 Earnings Call Transcript

The Joint Corp. (NASDAQ:JYNT ) Q2 2023 Earnings Conference Call August 10, 2023 5:00 PM ET Company Participants Kirsten Chapman - Investor Relations Peter Holt - President and Chief Executive Officer Jake Singleton - Chief Financial Officer Conference Call Participants Jeremy Hamblin - Craig-Hallum Capital Group Jeff Van Sinderen - B. Riley Thomas McGovern - Maxim Group George Kelly - ROTH MKM Operator Hello, and welcome to The Joint Corp. Second Quarter 2023 Financial Results Conference Call.

12:10 29 Sep 2023 JYNT

The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit

The Joint (JYNT) moves from the 800th to the 900th clinic milestone in less than a year.

07:05 29 Sep 2023 JYNT

The Joint Corp. to Host Conference Call on Thursday, August 10th to Discuss Second Quarter 2023 Results

SCOTTSDALE, Ariz., July 13, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its second quarter 2023 financial results on Thursday, August 10, 2023, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.

09:34 29 Sep 2023 JYNT

The Joint (JYNT) Buys Wisconsin Regional Developer Zone Rights

The Joint (JYNT) expects the Wisconsin region to hold a total of 53 clinics, of which 21 are currently operating.

11:35 29 Sep 2023 JYNT

The Joint Corp. (JYNT) Surges 10.0%: Is This an Indication of Further Gains?

The Joint Corp. (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

07:05 29 Sep 2023 JYNT

The Joint Corp. to Participate in Upcoming Conferences

SCOTTSDALE, Ariz., May 15, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that management plans to participate in and conduct one-on-one meetings at these upcoming conferences.

JYNT Financial details

Company Rating

Strong Buy

Market Cap

142.84M

Income

3.15M

Revenue

112.17M

Book val./share

2.42

Cash/share

0.93

Dividend

Dividend %

Employees

359

Optionable

Shortable

Yes

Earnings

01 Nov 2023

P/E

42.53

Forward P/E

PEG

-7.51

P/S

1.2

P/B

3.76

P/C

9.81

P/FCF

11.77

Quick Ratio

0.69

Current Ratio

0.9

Debt / Equity

0.79

LT Debt / Equity

0.62

EPS (TTM)

0.22

EPS next Y

EPS next Q

0.07

EPS this Y

-84%

EPS next Y

EPS next 5Y

26.73%

EPS last 5Y

34.02%

Revenue last 5Y

26.24%

Revenue Q/Q

3.01%

EPS Q/Q

-108.13%

SMA20

-1.77%

SMA50

-30.2%

SMA100

-39.4%

Inst Own

83.47%

Inst Trans

ROA

ROE

ROC

0.02%

Gross Margin

91%

Oper. Margin

Profit Margin

Payout

Shs Outstand

14.74M

Shs Float

10.53M

Target Price

52W Range

8.76-20.0

52W High

-54.4%

52W Low

+14%

RSI

35.04

Rel Volume

0.68

Avg Volume

148.51K

Volume

100.6K

Perf Week

-5.59%

Perf Month

-16.56%

Perf Quarter

-42.75%

Perf Half Y

-43.25%

Beta

1.44156

Volatility

0.19%, 0.28%

Prev Close

-1.41%

Price

9.12

Change

-2.25%

JYNT Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	2.33	3.51	4.19	5.67	7.03
Net income per share	0.02	0.24	0.94	0.5	0.08
Operating cash flow per share	0.4	0.54	0.8	1.06	0.77
Free cash flow per share	0.3	0.24	0.5	0.48	0.16
Cash per share	0.64	0.61	1.47	1.36	0.67
Book value per share	0.17	0.41	1.48	2.06	2.23
Tangible book value per share	-0.16	-0.12	0.95	1.33	0.76
Share holders equity per share	0.17	0.41	1.48	2.06	2.23
Interest debt per share	0.13	1.03	1.32	1.57	1.86
Market cap	113.73M	223.04M	367.74M	940.64M	202.55M
Enterprise value	106.11M	228.86M	365.66M	943.57M	218.86M
P/E ratio	449.37	67.11	27.93	131.39	172.05
Price to sales ratio	3.58	4.6	6.27	11.59	1.99
POCF ratio	20.86	29.65	32.88	61.75	18.27
PFCF ratio	27.99	66.44	52.63	137.23	87.66
P/B Ratio	48.16	38.99	17.72	31.85	6.26
PTB ratio	48.16	38.99	17.72	31.85	6.26
EV to sales	3.34	4.72	6.23	11.62	2.15
Enterprise value over EBITDA	36.7	41.44	45.01	77.59	20.76
EV to operating cash flow	19.46	30.43	32.7	61.94	19.74
EV to free cash flow	26.12	68.18	52.33	137.66	94.72
Earnings yield	0	0.01	0.04	0.01	0.01
Free cash flow yield	0.04	0.02	0.02	0.01	0.01
Debt to equity	0.77	2.5	0.89	0.76	0.8
Debt to assets	0.08	0.33	0.28	0.27	0.28
Net debt to EBITDA	-2.63	1.05	-0.26	0.24	1.55
Current ratio	1.34	0.98	1.35	1.17	0.76
Interest coverage	0	0	0	0	3.04
Income quality	21.54	2.26	0.85	2.13	9.42
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0.33
Sales general and administrative to revenue	0.64	0.63	0.62	0.61	0.67
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.19	0.17	0.11	0.12	0.23
Capex to operating cash flow	-0.25	-0.55	-0.38	-0.55	-0.79
Capex to revenue	-0.04	-0.09	-0.07	-0.1	-0.09
Capex to depreciation	-0.89	-2.19	-1.53	-1.38	-1.15
Stock based compensation to revenue	0.02	0.01	0.02	0.01	0.01
Graham number	0.27	1.5	5.6	4.82	2.02
ROIC	0.06	0.1	0.25	0.1	0.02
Return on tangible assets	0.01	0.09	0.23	0.1	0.02
Graham Net	-0.81	-1.95	-1.6	-2.22	-3.17
Working capital	2.97M	-262.64K	6.45M	3.77M	-5.5M
Tangible asset value	-2.19M	-1.65M	13.26M	19.07M	11.04M
Net current asset value	-9.45M	-24.68M	-19.85M	-27.9M	-41.93M
Invested capital	0.77	2.5	0.89	0.76	0.8
Average receivables	1.34M	2.07M	2.31M	2.62M	3.65M
Average payables	1.16M	1.39M	1.54M	1.63M	2.34M
Average inventory	668.51K	850.26K	1.06M	1.27M	1.62M
Days sales outstanding	15.65	20.9	11.51	15.24	14.01
Days payables outstanding	106.13	100.06	87.59	73.12	110.15
Days of inventory on hand	63.44	62.39	65.23	59.2	69.04
Receivables turnover	23.32	17.47	31.71	23.94	26.06
Payables turnover	3.44	3.65	4.17	4.99	3.31
Inventory turnover	5.75	5.85	5.6	6.17	5.29
ROE	0.11	0.58	0.63	0.24	0.04
Capex per share	-0.1	-0.3	-0.3	-0.59	-0.61

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2022-06-30	2022-09-30	2022-12-31	2023-03-31	2023-06-30
Revenue per share	1.73	1.83	1.91	1.95	2
Net income per share	0.02	0.03	0.04	0.16	-0.01
Operating cash flow per share	0.07	0.29	0.37	0.41	0.1
Free cash flow per share	-0.23	0.21	0.25	0.33	0
Cash per share	0.65	0.71	0.67	1.01	0.93
Book value per share	2.1	2.17	2.23	2.41	2.42
Tangible book value per share	0.92	0.89	0.76	1.01	1.16
Share holders equity per share	2.1	2.17	2.23	2.41	2.42
Interest debt per share	1.74	1.73	1.81	1.66	1.91
Market cap	221.62M	228M	203.13M	245.15M	198.23M
Enterprise value	237.25M	242.22M	219.44M	258.29M	212.62M
P/E ratio	160.72	116.06	92.8	26.63	-260.31
Price to sales ratio	8.84	8.57	7.3	8.62	6.76
POCF ratio	217.86	54.06	37.6	40.69	134.99
PFCF ratio	-68.03	74.52	56.41	50.81	-3.24K
P/B Ratio	7.28	7.24	6.27	6.99	5.57
PTB ratio	7.28	7.24	6.27	6.99	5.57
EV to sales	9.47	9.1	7.89	9.08	7.25
Enterprise value over EBITDA	100.9	79.65	59.59	143.88	94.77
EV to operating cash flow	233.22	57.43	40.62	42.87	144.78
EV to free cash flow	-72.83	79.17	60.94	53.54	-3.48K
Earnings yield	0	0	0	0.01	0
Free cash flow yield	-0.01	0.01	0.02	0.02	0
Debt to equity	0.82	0.78	0.8	0.8	0.79
Debt to assets	0.29	0.28	0.28	0.28	0.28
Net debt to EBITDA	6.64	4.68	4.43	7.32	6.41
Current ratio	0.87	0.87	0.76	0.94	0.9
Interest coverage	3.3	1.86	7.41	0.15	0
Income quality	2.95	8.59	9.87	2.62	-8.89
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0.06	0
Sales general and administrative to revenue	0.66	0.67	0.66	0.7	0.68
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.2	0.21	0.23	0.21	0.19
Capex to operating cash flow	-4.2	-0.27	-0.33	-0.2	-1.04
Capex to revenue	-0.17	-0.04	-0.06	-0.04	-0.05
Capex to depreciation	-2.51	-0.58	-0.78	-0.51	-0.69
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	1.06	1.29	1.37	2.93	0.84
ROIC	0.01	0.01	0.01	0	0
Return on tangible assets	0	0.01	0.01	0.03	0
Graham Net	-2.94	-2.93	-3.16	-3.06	-3.16
Working capital	-2.53M	-2.72M	-5.5M	-1.41M	-2.41M
Tangible asset value	13.32M	12.87M	11.04M	14.7M	17.06M
Net current asset value	-38.05M	-37.84M	-41.93M	-39.39M	-41.17M
Invested capital	0.82	0.78	0.8	0.8	0.79
Average receivables	3.59M	3.75M	3.93M	3.72M	3.53M
Average payables	1.72M	1.78M	2.47M	2.4M	1.71M
Average inventory	1.9M	2.1M	1.92M	1.82M	1.96M
Days sales outstanding	12.79	13.35	12.66	11.15	10.86
Days payables outstanding	58.29	71.64	102.69	63	54.65
Days of inventory on hand	82.59	71.28	64.36	61.41	73.62
Receivables turnover	7.04	6.74	7.11	8.07	8.29
Payables turnover	1.54	1.26	0.88	1.43	1.65
Inventory turnover	1.09	1.26	1.4	1.47	1.22
ROE	0.01	0.02	0.02	0.07	-0.01
Capex per share	-0.3	-0.08	-0.12	-0.08	-0.1

JYNT Frequently Asked Questions

What is The Joint Corp. stock symbol ?

The Joint Corp. is a US stock , located in Scottsdale of Az and trading under the symbol JYNT

What is The Joint Corp. stock quote today ?

The Joint Corp. stock price is $9.12 today.

Is The Joint Corp. stock public?

Yes, The Joint Corp. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 148.51K
Market Capitalization 142.84M
Employee 359
CEO Mr. Peter D. Holt
Headquarters Scottsdale,AZ,US
IPO Date 2014-11-11
Website https://www.thejoint.com

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.